Di Bacco, A., Bahlis, N. J., Munshi, N. C., Avet‐Loiseau, H., Masszi, T., Viterbo, L., . . . Moreau, P. (2020). c‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma. Eur J Haematol.
Citação norma ChicagoDi Bacco, Alessandra, et al. "C‐MYC Expression and Maturity Phenotypes Are Associated With Outcome Benefit From Addition of Ixazomib to Lenalidomide‐dexamethasone in Myeloma." Eur J Haematol 2020.
Citação norma MLADi Bacco, Alessandra, et al. "C‐MYC Expression and Maturity Phenotypes Are Associated With Outcome Benefit From Addition of Ixazomib to Lenalidomide‐dexamethasone in Myeloma." Eur J Haematol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.